Intravenous landiolol, a novel β (1)-adrenergic blocker for patients with cardiac dysfunction and atrial fibrillation.
1 July 2021 (11:25 - 11:40)
Organised by:
About the speaker
Ordensklinikum Linz Elisabethinen, Linz (Austria)
4 More presentations in this session
Access the full session
The Event
Heart Failure 2021
1 July 2021
11:25 CET
You may be interested in
Congress Session
